Hyperuricemia (HUA) is a type of purine metabolism disease and Simiao Pill (SMP), a
classic herbal prescription, has a long history of treating HUA. Nonetheless, the mechanisms …

Objective. Hyperuricemia (HUA) is a common metabolic disease caused by disordered
purine metabolism. We aim to reveal the mechanisms underlying the anti‐HUA function of …

Objective To explore the mechanism of Simiao pills for treatment of hyperuricemia based on
network pharmacology and molecular docking. Objective The active ingredients of Simiao …

Hyperuricemia is characterized by an excessive accumulation of uric acid in the joints, and
this condition remains a therapeutic challenge with limited options and significant side …

A network pharmacology integrated molecular docking strategy was used to predict the
underlying molecular mechanism of Ermiao san in the treatment of hyperuricemia and gout …

In this research, based on an important target xanthine dehydrogenase/oxidase (XDH/XO) of
therapeutical hyperuricemia, natural multitarget XO inhibitors are discovered from Chinese …

To achieve potential alternatives for hyperuricemia therapeutics, a novel structure‐docking
energy relationship model was established for high‐throughput screening inhibitors of …

Xanthine Oxidase inhibitors treat hyperuricemia, but associated side effects have led
researchers to discover new inhibitors with fewer side effects. Our study employed a hybrid …

Background Hyperuricemia (HUA) is a major public health issue with a high prevalence
worldwide. Wuling San (WLS) is an effective treatment for HUA. However, the active …

Background Hyperuricemia is a more popular metabolic disease caused by a disorder of
purine metabolism. Our previous study firstly screened out a natural product Isobavachin as …